Suivre
Andrew Morin
Andrew Morin
Synthekine, Inc
Adresse e-mail validée de hms.harvard.edu
Titre
Citée par
Citée par
Année
Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs
T Bepler, A Morin, M Rapp, J Brasch, L Shapiro, AJ Noble, B Berger
Nature methods 16 (11), 1153-1160, 2019
10732019
Collaboration gets the most out of software
A Morin, B Eisenbraun, J Key, PC Sanschagrin, MA Timony, M Ottaviano, ...
elife 2, e01456, 2013
10012013
Shining light into black boxes
A Morin, J Urban, PD Adams, I Foster, A Sali, D Baker, P Sliz
Science 336 (6078), 159-160, 2012
2292012
MicroRNA-223 is a crucial mediator of PPARγ-regulated alternative macrophage activation
W Ying, A Tseng, RCA Chang, A Morin, T Brehm, K Triff, V Nair, G Zhuang, ...
The Journal of clinical investigation 125 (11), 4149-4159, 2015
1492015
A quick guide to software licensing for the scientist-programmer
A Morin, J Urban, P Sliz
Public Library of Science 8 (7), e1002598, 2012
1142012
miR-150 regulates obesity-associated insulin resistance by controlling B cell functions
W Ying, A Tseng, RCA Chang, H Wang, Y Lin, S Kanameni, T Brehm, ...
Scientific reports 6 (1), 20176, 2016
882016
Diets deficient in indispensable amino acids rapidly decrease the concentration of the limiting amino acid in the anterior piriform cortex of rats
TJ Koehnle, MC Russell, AS Morin, LF Erecius, DW Gietzen
The Journal of nutrition 134 (9), 2365-2371, 2004
502004
Effect of early-stage autophagy inhibition in BRAFV600E autophagy-dependent brain tumor cells
S Zahedi, BE Fitzwalter, A Morin, S Grob, M Desmarais, A Nellan, ...
Cell Death & Disease 10 (9), 679, 2019
352019
Computational design of protein–ligand interfaces: potential in therapeutic development
A Morin, J Meiler, LS Mizoue
Trends in biotechnology 29 (4), 159-166, 2011
342011
Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAFV600E-Mutant Human Glioma
KC Schreck, A Morin, G Zhao, AN Allen, P Flannery, M Glantz, AL Green, ...
Clinical Cancer Research 27 (22), 6197-6208, 2021
302021
Computational design of an endo-1, 4-β-xylanase ligand binding site
A Morin, KW Kaufmann, C Fortenberry, JM Harp, LS Mizoue, J Meiler
Protein Engineering, Design & Selection 24 (6), 503-516, 2011
262011
IRF6 Regulates Alternative Activation by Suppressing PPARγ in Male Murine Macrophages
C Li, W Ying, Z Huang, T Brehm, A Morin, AT Vella, B Zhou
Endocrinology 158 (9), 2837-2847, 2017
252017
TOPAZ: A positive-unlabeled convolutional neural network CryoEM particle picker that can pick any size and shape particle
T Bepler, A Morin, M Rapp, J Brasch, L Shapiro, AJ Noble, B Berger
Microscopy and Microanalysis 25 (S2), 986-987, 2019
212019
Structural biology computing: Lessons for the biomedical research sciences
A Morin, P Sliz
Biopolymers 99 (11), 809-816, 2013
132013
Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Research in computational molecular biology
T Bepler, A Morin, AJ Noble, J Brasch, L Shapiro, B Berger
Annual International Conference, RECOMB proceedings 10812, 245-247, 2018
72018
AppCiter: a web application for increasing rates and accuracy of scientific software citation
SM Socias, A Morin, MA Timony, P Sliz
Structure 23 (5), 807-808, 2015
72015
Optimizing peer review of software code
P Sliz, A Morin
Science 341 (6143), 236-237, 2013
42013
Engineered cd25 polypeptides and uses thereof
MP Greving, PT Gip, M Srinivasan, A Morin, KE Hauser, JR Willis, ...
US Patent App. 17/320,118, 2023
2023
Meso-scale engineered peptides and methods of selecting
MP Greving, KE Hauser, A Morin, JR Willis
US Patent App. 17/537,215, 2022
2022
RARE-18. NF1-MUTATED TUMORS EXHIBIT INCREASED SENSITIVITY TO AUTOPHAGY INHIBITION ALONE AND IN COMBINATION WITH MEK INHIBITION
E Baird-Daniel, S Zahedi, A Morin, M Desmarais, K Williams, R Williams, ...
Neuro-Oncology 23 (Supplement_1), i44-i44, 2021
2021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20